Through the CREB/BDNF axis, Sem increases remyelination and overcomes demyelination, therefore can amend experimental autoimmune encephalomyelitis (EAE)-induced multiple sclerosis in mice (Sadek et al. 2023). This evidence concerns the gene CREB1 and experimental autoimmune encephalomyelitis.